NBC Securities Inc. Has $3.68 Million Position in Stryker Co. (NYSE:SYK)

NBC Securities Inc. boosted its stake in Stryker Co. (NYSE:SYK - Free Report) by 109,777.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 9,889 shares of the medical technology company's stock after acquiring an additional 9,880 shares during the quarter. NBC Securities Inc.'s holdings in Stryker were worth $3,681,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Capital & Planning LLC lifted its holdings in Stryker by 3.6% in the 4th quarter. Capital & Planning LLC now owns 841 shares of the medical technology company's stock valued at $304,000 after purchasing an additional 29 shares in the last quarter. Brighton Jones LLC raised its holdings in Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock valued at $1,643,000 after buying an additional 609 shares during the period. Crews Bank & Trust acquired a new position in Stryker in the 4th quarter valued at about $39,000. Austin Private Wealth LLC acquired a new position in Stryker in the 4th quarter valued at about $226,000. Finally, Heck Capital Advisors LLC acquired a new position in Stryker in the 4th quarter valued at about $662,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Stryker Trading Up 0.3%

Shares of NYSE SYK traded up $1.28 during mid-day trading on Thursday, hitting $383.83. 286,824 shares of the company traded hands, compared to its average volume of 1,329,387. Stryker Co. has a 1 year low of $314.93 and a 1 year high of $406.19. The stock has a market capitalization of $146.50 billion, a price-to-earnings ratio of 49.46, a PEG ratio of 2.93 and a beta of 0.93. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The business has a 50 day moving average of $369.68 and a two-hundred day moving average of $376.11.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The business had revenue of $5.87 billion during the quarter, compared to analyst estimates of $5.68 billion. During the same period in the previous year, the company earned $2.50 EPS. The firm's revenue was up 11.9% on a year-over-year basis. On average, sell-side analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.88%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio is currently 45.41%.

Wall Street Analyst Weigh In

SYK has been the subject of a number of analyst reports. Barclays boosted their price objective on Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a research report on Monday, February 10th. Truist Financial increased their price objective on Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a report on Monday, May 5th. JMP Securities restated a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. The Goldman Sachs Group set a $422.00 price target on Stryker in a research note on Tuesday, March 4th. Finally, Sanford C. Bernstein set a $450.00 price objective on Stryker in a research report on Monday, May 5th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Stryker presently has a consensus rating of "Moderate Buy" and a consensus price target of $427.30.

Insider Activity

In related news, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.90% of the stock is currently owned by company insiders.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.